QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 2.05
-- x --
-- x --
-- - --
$ 1.85 - $ 6.73
1,678
na
na
$ 0.70
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 shl-telemedicine-h1-eps-024-up-from-025-yoy-sales-2790m-down-from-2900m-yoy

SHL Telemedicine (NASDAQ:SHLT) reported quarterly losses of $(0.24) per share. This is a 4 percent increase over losses of $(0....

 shl-telemedicine-names-david-arnon-as-ceo-effective-august-6-2024

David Arnon held senior leadership and CEO roles within the healthcare insurance industry at Harel Insurance and Clal Insurance...

 shl-telemedicine-expands-offering-in-israel-with-groundbreaking-at-home-biomarker-blood-test

Users in Israel will be able for the first time in the world to perform an at-home Biomarker blood test guided by SHL's med...

 imperial-college-study-reveals-shl-telemedicines-smartheart-drastically-cuts-hospital-readmissions-by-76-and-lowers-emergency-visits-by-41

Groundbreaking Study reveals a 76% drop in hospital readmissions and a 41% decrease in Emergency Department visits, underscorin...

 shls-smartheart-ecg-technology-showcases-potential-in-us-armys-largest-field-experiment

SHL Telemedicine Ltd. (NASDAQ:SHLT, SIX: SHLTN, )))) ("SHL" or the "Company"), a leading provider and developer...

 litchfield-hills-initiates-coverage-on-shl-telemedicine-with-buy-rating-announces-price-target-of-11

Litchfield Hills analyst Theodore O'Neill initiates coverage on SHL Telemedicine (NASDAQ:SHLT) with a Buy rating and ann...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION